,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Acute myocardial infarction,1,16153099
0,22.0,Pneumonia,5,16153103
0,22.0,Pulmonary embolism,1,16153113
0,22.0,Purpura,2,16153154
1,22.0,Rash maculo-papular,2,16153154
0,22.0,Hepatotoxicity,2,16153156
0,22.0,Blood pressure decreased,6,16153167
1,22.0,Oropharyngeal discolouration,6,16153167
2,22.0,Oropharyngeal pain,6,16153167
3,22.0,Delirium,3,16153167
0,22.0,Rash pruritic,2,16153191
0,22.0,Extremity necrosis,2,16153251
1,22.0,Skin ulcer,2,16153251
0,22.0,Blood creatinine increased,1,16153260
1,22.0,Gamma-glutamyltransferase increased,1,16153260
2,22.0,Transaminases increased,1,16153260
3,22.0,Liver injury,1,16153260
4,22.0,Blood alkaline phosphatase increased,1,16153260
5,22.0,Thrombocytopenia,1,16153260
0,22.0,Myalgia,1,16153264
1,22.0,Thyroid disorder,6,16153264
2,22.0,Condition aggravated,3,16153264
3,22.0,Malaise,6,16153264
4,22.0,Product dose omission,6,16153264
5,22.0,Dizziness,1,16153264
6,22.0,Blood phosphorus decreased,6,16153264
7,22.0,Constipation,3,16153264
8,22.0,White blood cell count decreased,6,16153264
9,22.0,Head discomfort,1,16153264
10,22.0,Balance disorder,1,16153264
11,22.0,Insomnia,3,16153264
0,22.0,Stomatitis,1,16153270
1,22.0,Oral pain,1,16153270
0,22.0,Pulmonary embolism,6,16153304
1,22.0,Thrombosis,6,16153304
0,22.0,Breast cancer metastatic,6,16153342
1,22.0,Malignant neoplasm progression,6,16153342
0,22.0,Cerebral haemorrhage,2,16153346
0,22.0,Dermatitis acneiform,1,16153353
0,22.0,Febrile neutropenia,1,16153391
0,22.0,Leukoencephalopathy,2,16153417
0,22.0,Metastases to liver,6,16153448
1,22.0,Bone lesion,6,16153448
2,22.0,Off label use,6,16153448
3,22.0,Pulmonary mass,6,16153448
4,22.0,Bone pain,6,16153448
5,22.0,Intentional product use issue,6,16153448
6,22.0,Pleural thickening,6,16153448
0,22.1,Peripheral swelling,3,16153449
1,22.1,Nausea,3,16153449
2,22.1,Pneumonia,3,16153449
3,22.1,Hepatic enzyme increased,3,16153449
4,22.1,Ejection fraction,3,16153449
5,22.1,Gamma-glutamyltransferase increased,3,16153449
6,22.1,Epistaxis,3,16153449
7,22.1,Malignant neoplasm progression,3,16153449
8,22.1,Ill-defined disorder,3,16153449
9,22.1,Metastases to lymph nodes,3,16153449
10,22.1,Aspartate aminotransferase increased,3,16153449
11,22.1,Rash,3,16153449
12,22.1,Blood pressure increased,3,16153449
13,22.1,Pulmonary oedema,3,16153449
14,22.1,Fatigue,3,16153449
15,22.1,Asthenopia,3,16153449
16,22.1,Pulmonary mass,3,16153449
17,22.1,Blood lactate dehydrogenase increased,3,16153449
18,22.1,Blood alkaline phosphatase increased,3,16153449
19,22.1,Flushing,3,16153449
20,22.1,Alanine aminotransferase increased,3,16153449
21,22.1,Hypersensitivity,3,16153449
22,22.1,Nasopharyngitis,3,16153449
23,22.1,Metastases to bone,3,16153449
24,22.1,Infusion related reaction,3,16153449
0,22.0,Interstitial lung disease,5,16153483
0,22.0,Pneumonitis,1,16153489
1,22.0,Cerebral disorder,6,16153489
0,22.0,Coagulopathy,6,16153510
0,22.0,Chronic lymphocytic leukaemia,6,16153514
0,22.0,Weight decreased,6,16153543
1,22.0,General physical health deterioration,6,16153543
2,22.0,Death,5,16153543
3,22.0,Adverse event,6,16153543
4,22.0,Product use in unapproved indication,6,16153543
0,22.0,Pneumonia,1,16153556
0,22.0,Diffuse large B-cell lymphoma,5,16153581
0,22.0,Cerebral infarction,3,16153612
0,22.0,Melaena,1,16153630
1,22.0,Diarrhoea,1,16153630
0,22.0,Bone marrow failure,1,16153697
1,22.0,Hepatic function abnormal,1,16153697
0,22.0,Rash,6,16153725
1,22.0,Skin exfoliation,6,16153725
2,22.0,Genital rash,6,16153725
0,22.0,Neoplasm progression,6,16153729
1,22.0,White blood cell count decreased,6,16153729
2,22.0,Tumour marker increased,6,16153729
0,22.0,Neoplasm progression,3,16153766
1,22.0,Neutrophil count decreased,3,16153766
2,22.0,Paraesthesia,6,16153766
0,22.1,Hepatitis,4,16153867
0,22.1,Back pain,1,16153871
1,22.1,Pneumonia,1,16153871
0,22.1,Breast pain,6,16153872
1,22.1,Visual impairment,6,16153872
0,22.0,Diarrhoea,1,16153878
0,22.0,Road traffic accident,6,16153885
0,22.0,Second primary malignancy,6,16153898
1,22.0,Migraine,3,16153898
2,22.0,Mood swings,6,16153898
3,22.0,Dry skin,3,16153898
4,22.0,Fatigue,3,16153898
5,22.0,Pelvic pain,6,16153898
6,22.0,Agitation,6,16153898
7,22.0,Mouth swelling,6,16153898
8,22.0,Eye disorder,3,16153898
9,22.0,Lacrimation decreased,6,16153898
10,22.0,Feeling abnormal,3,16153898
11,22.0,Arthralgia,6,16153898
12,22.0,Dysphagia,6,16153898
13,22.0,Malaise,3,16153898
14,22.0,Rash,6,16153898
15,22.0,Hot flush,6,16153898
16,22.0,Pain in extremity,6,16153898
17,22.0,Dry mouth,6,16153898
18,22.0,Pain of skin,3,16153898
19,22.0,Hypersomnia,3,16153898
20,22.0,Myalgia,6,16153898
21,22.0,Odynophagia,6,16153898
22,22.0,Headache,3,16153898
23,22.0,Peripheral swelling,6,16153898
24,22.0,Dyspnoea,6,16153898
25,22.0,Bone pain,6,16153898
26,22.0,Lip and/or oral cavity cancer,6,16153898
27,22.0,Cardiovascular disorder,6,16153898
28,22.0,Pruritus,6,16153898
29,22.0,Dry eye,3,16153898
30,22.0,Insomnia,6,16153898
31,22.0,Pain,6,16153898
32,22.0,Oral pain,6,16153898
33,22.0,Oral infection,6,16153898
0,22.0,Jaundice,5,16153959
1,22.0,Diarrhoea,1,16153959
0,22.0,Madarosis,3,16153962
1,22.0,Hair texture abnormal,3,16153962
2,22.0,Alopecia,6,16153962
0,22.0,Death,5,16153989
0,22.0,Pneumonia,6,16154000
1,22.0,Headache,6,16154000
2,22.0,Product dose omission,6,16154000
3,22.0,Dizziness,6,16154000
0,22.0,Death,5,16154029
0,22.0,Generalised oedema,5,16154032
1,22.0,Pulmonary oedema,5,16154032
2,22.0,Febrile neutropenia,2,16154032
3,22.0,Volume blood decreased,6,16154032
4,22.0,Hypoalbuminaemia,6,16154032
5,22.0,Hypercapnia,6,16154032
6,22.0,Multiple organ dysfunction syndrome,5,16154032
7,22.0,Acute respiratory distress syndrome,5,16154032
8,22.0,Dyspnoea exertional,5,16154032
9,22.0,Feeding disorder,6,16154032
10,22.0,Hypoxia,6,16154032
11,22.0,Hyponatraemia,6,16154032
12,22.0,Weight increased,5,16154032
13,22.0,Sepsis,6,16154032
14,22.0,Gastrointestinal oedema,5,16154032
15,22.0,Disseminated intravascular coagulation,5,16154032
16,22.0,Acidosis,5,16154032
17,22.0,Oliguria,6,16154032
18,22.0,Hypotension,6,16154032
19,22.0,Decreased appetite,5,16154032
20,22.0,Oral disorder,6,16154032
21,22.0,Pulmonary congestion,6,16154032
22,22.0,Pleural effusion,5,16154032
23,22.0,Hepatic failure,5,16154032
24,22.0,Ileus,5,16154032
25,22.0,Prerenal failure,6,16154032
26,22.0,Pyrexia,6,16154032
0,22.0,Product use in unapproved indication,6,16154042
1,22.0,Off label use,6,16154042
2,22.0,Malignant transformation,6,16154042
0,22.0,Jaundice cholestatic,2,16154049
1,22.0,Hepatocellular injury,2,16154049
2,22.0,Drug interaction,2,16154049
0,22.0,Hot flush,1,16154067
1,22.0,Headache,1,16154067
0,22.1,Amnesia,1,16154080
1,22.1,Brain oedema,6,16154080
2,22.1,Cognitive disorder,1,16154080
0,22.0,Pneumonia cytomegaloviral,5,16154081
1,22.0,Interstitial lung disease,5,16154081
2,22.0,Pneumonia bacterial,5,16154081
0,22.0,Infection,6,16154167
1,22.0,Drug ineffective,6,16154167
0,22.1,Hair colour changes,1,16154193
1,22.1,Hair disorder,1,16154193
2,22.1,Alopecia,1,16154193
3,22.1,Depression,6,16154193
4,22.1,Hair texture abnormal,1,16154193
5,22.1,Madarosis,1,16154193
0,22.0,Alopecia,3,16154194
1,22.0,Hair texture abnormal,3,16154194
2,22.0,Hair colour changes,3,16154194
3,22.0,Madarosis,1,16154194
4,22.0,Hair disorder,3,16154194
0,22.0,Confusional state,3,16154242
1,22.0,Balance disorder,3,16154242
2,22.0,Disorientation,3,16154242
3,22.0,Acute kidney injury,2,16154242
4,22.0,Asthenia,3,16154242
5,22.0,Speech disorder,3,16154242
6,22.0,Decreased appetite,3,16154242
0,22.0,Neuralgia,3,16154266
1,22.0,Pruritus generalised,6,16154266
2,22.0,Skin burning sensation,6,16154266
0,22.0,Cardiac failure,6,16154269
0,22.0,Psoriasis,3,16154307
0,22.0,Electrocardiogram QT prolonged,6,16154322
1,22.0,Electrocardiogram repolarisation abnormality,6,16154322
0,22.0,Crepitations,6,16154338
0,22.0,Cardiac failure,6,16154348
0,22.0,Obstruction gastric,1,16154415
1,22.0,Bone pain,1,16154415
2,22.0,Vomiting,1,16154415
3,22.0,Fatigue,1,16154415
4,22.0,Constipation,1,16154415
5,22.0,Vomiting,1,16154415
6,22.0,Hyperhidrosis,1,16154415
0,22.0,Large intestine perforation,1,16154427
0,22.0,Thrombocytopenia,6,16154429
1,22.0,Drug specific antibody,6,16154429
2,22.0,Coombs positive haemolytic anaemia,6,16154429
3,22.0,Coombs indirect test positive,6,16154429
0,22.0,Arrhythmia,6,16154515
1,22.0,Nausea,6,16154515
2,22.0,Diarrhoea,6,16154515
3,22.0,Intestinal perforation,6,16154515
4,22.0,Rash,6,16154515
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16154515
6,22.0,Febrile neutropenia,6,16154515
7,22.0,Subileus,6,16154515
8,22.0,Vomiting,6,16154515
9,22.0,Anaemia,6,16154515
10,22.0,Nail disorder,6,16154515
11,22.0,Pulmonary embolism,6,16154515
12,22.0,Proteinuria,6,16154515
13,22.0,Neutropenia,6,16154515
14,22.0,Epistaxis,6,16154515
15,22.0,Ileus,6,16154515
16,22.0,Deep vein thrombosis,6,16154515
17,22.0,Mucosal inflammation,6,16154515
18,22.0,Malignant hypertension,6,16154515
19,22.0,Neuropathy peripheral,6,16154515
20,22.0,Thrombocytopenia,6,16154515
21,22.0,Dehydration,6,16154515
22,22.0,Constipation,6,16154515
0,22.0,Depression,6,16154595
1,22.0,Alopecia,3,16154595
2,22.0,Madarosis,3,16154595
0,22.0,Intentional dose omission,6,16154598
1,22.0,Neoplasm progression,2,16154598
2,22.0,Pain in extremity,6,16154598
3,22.0,Burning sensation,6,16154598
4,22.0,Feeling abnormal,6,16154598
5,22.0,Cheilitis,1,16154598
6,22.0,Chills,6,16154598
7,22.0,Lymph node pain,3,16154598
8,22.0,Bone marrow failure,2,16154598
9,22.0,Rash pruritic,6,16154598
10,22.0,Weight increased,6,16154598
11,22.0,Condition aggravated,3,16154598
12,22.0,Fatigue,3,16154598
13,22.0,Pain,3,16154598
14,22.0,Dry mouth,3,16154598
0,22.0,Alopecia,6,16154599
1,22.0,Onychoclasis,6,16154599
0,22.1,Asthenia,6,16154600
1,22.1,Product dose omission,6,16154600
2,22.1,Fatigue,6,16154600
3,22.1,Neutropenia,1,16154600
4,22.1,Blood count abnormal,1,16154600
0,22.0,Decreased appetite,6,16154626
1,22.0,Headache,6,16154626
2,22.0,Platelet count decreased,2,16154626
3,22.0,White blood cell count decreased,2,16154626
4,22.0,Meningitis,6,16154626
5,22.0,Blood pressure increased,6,16154626
6,22.0,Neoplasm progression,6,16154626
7,22.0,Nausea,6,16154626
8,22.0,Nausea,6,16154626
9,22.0,Hypertension,6,16154626
10,22.0,Pruritus,6,16154626
11,22.0,Hepatic enzyme increased,6,16154626
12,22.0,Vomiting,6,16154626
0,22.0,Sepsis,5,16154632
1,22.0,Hypertensive crisis,1,16154632
2,22.0,Humerus fracture,2,16154632
3,22.0,Cholangitis,6,16154632
4,22.0,Subclavian vein thrombosis,2,16154632
5,22.0,Diarrhoea,2,16154632
0,22.0,Ventricular tachycardia,6,16154640
1,22.0,Autoimmune hypothyroidism,6,16154640
2,22.0,Syncope,6,16154640
3,22.0,Anaemia of malignant disease,6,16154640
4,22.0,Weight decreased,6,16154640
5,22.0,Lymphadenopathy mediastinal,6,16154640
6,22.0,General physical health deterioration,6,16154640
7,22.0,Hypercalcaemia,6,16154640
8,22.0,Ascites,6,16154640
9,22.0,Lumbar vertebral fracture,6,16154640
10,22.0,Muscular weakness,6,16154640
11,22.0,Pleural effusion,6,16154640
12,22.0,Autoimmune thyroiditis,6,16154640
0,22.0,Metastases to central nervous system,5,16154646
1,22.0,Inadequate analgesia,1,16154646
2,22.0,Lung neoplasm malignant,5,16154646
0,22.0,Off label use,6,16154656
1,22.0,Blood count abnormal,6,16154656
0,22.0,Hypotension,5,16154661
1,22.0,Off label use,6,16154661
2,22.0,Blood creatinine increased,5,16154661
3,22.0,Platelet count decreased,5,16154661
4,22.0,Blood urea increased,5,16154661
5,22.0,Neutrophil count decreased,5,16154661
6,22.0,Neutropenic sepsis,5,16154661
0,22.0,Interstitial lung disease,2,16154665
0,22.0,Pain,6,16154669
1,22.0,Neoplasm progression,6,16154669
2,22.0,Feeling abnormal,6,16154669
3,22.0,Death,5,16154669
4,22.0,Liver function test abnormal,6,16154669
5,22.0,Dysphagia,6,16154669
6,22.0,Jaundice,6,16154669
7,22.0,Blood bilirubin increased,6,16154669
0,22.0,Liver disorder,1,16154672
1,22.0,Eye movement disorder,1,16154672
0,22.0,Restlessness,1,16154673
1,22.0,Altered state of consciousness,1,16154673
2,22.0,Bronchospasm,1,16154673
3,22.0,Erythema,1,16154673
0,22.0,Gastroenteritis,1,16154680
0,22.0,Atelectasis,6,16154699
1,22.0,Gastrooesophageal reflux disease,6,16154699
2,22.0,Plantar erythema,2,16154699
3,22.0,Bone pain,6,16154699
4,22.0,Burning sensation,6,16154699
5,22.0,Nervousness,6,16154699
6,22.0,Rash,1,16154699
7,22.0,Anxiety,6,16154699
8,22.0,Insomnia,6,16154699
9,22.0,Erythema,1,16154699
10,22.0,Carbohydrate antigen 125 increased,6,16154699
11,22.0,Dyspnoea,6,16154699
12,22.0,Nausea,3,16154699
13,22.0,Pruritus,1,16154699
14,22.0,Platelet count decreased,1,16154699
15,22.0,Arthralgia,6,16154699
16,22.0,Dizziness,6,16154699
17,22.0,Red blood cell count decreased,6,16154699
18,22.0,Pain in extremity,6,16154699
19,22.0,Pleural effusion,6,16154699
20,22.0,Constipation,6,16154699
21,22.0,Intentional product misuse,6,16154699
22,22.0,Neuropathy peripheral,6,16154699
23,22.0,Heart rate increased,3,16154699
24,22.0,Peripheral swelling,6,16154699
0,22.1,Arthralgia,6,16154718
1,22.1,Poor quality sleep,6,16154718
2,22.1,Hypertension,6,16154718
3,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16154718
4,22.1,Hypotension,3,16154718
5,22.1,Stomatitis,3,16154718
6,22.1,Skin exfoliation,6,16154718
7,22.1,Diarrhoea,6,16154718
8,22.1,Dehydration,6,16154718
9,22.1,Blister,6,16154718
10,22.1,Pneumonitis,2,16154718
11,22.1,Cellulitis,3,16154718
12,22.1,Nausea,3,16154718
13,22.1,Vomiting,3,16154718
0,22.0,Gastrointestinal haemorrhage,5,16154747
1,22.0,Respiratory arrest,5,16154747
0,22.0,Fulminant type 1 diabetes mellitus,3,16154776
1,22.0,Diabetic ketoacidosis,6,16154776
2,22.0,Adrenal insufficiency,2,16154776
3,22.0,Stomatitis,2,16154776
4,22.0,Hypophysitis,3,16154776
5,22.0,Enterocolitis,2,16154776
6,22.0,Duodenitis,3,16154776
7,22.0,Deep vein thrombosis,2,16154776
8,22.0,Lip swelling,3,16154776
9,22.0,Pulmonary embolism,2,16154776
10,22.0,Hypothyroidism,6,16154776
0,22.0,Hip fracture,6,16154813
1,22.0,Musculoskeletal stiffness,6,16154813
2,22.0,Nausea,6,16154813
3,22.0,Musculoskeletal disorder,6,16154813
0,22.0,Decreased appetite,3,16154824
1,22.0,Chest pain,3,16154824
2,22.0,Headache,3,16154824
3,22.0,Vomiting,1,16154824
4,22.0,Dysuria,3,16154824
5,22.0,Diarrhoea,3,16154824
6,22.0,Tremor,3,16154824
7,22.0,Feeding disorder,1,16154824
8,22.0,Back pain,3,16154824
9,22.0,Stomatitis,1,16154824
10,22.0,Blood pressure increased,3,16154824
11,22.0,Hypoaesthesia,1,16154824
12,22.0,Gingival pain,1,16154824
13,22.0,Diplopia,3,16154824
14,22.0,Dehydration,3,16154824
15,22.0,Balance disorder,3,16154824
16,22.0,Weight decreased,3,16154824
17,22.0,Seizure,1,16154824
18,22.0,Asthenia,1,16154824
19,22.0,Dry mouth,3,16154824
20,22.0,Urinary tract infection,1,16154824
21,22.0,Thyroid hormones decreased,1,16154824
22,22.0,Hypotension,3,16154824
23,22.0,Nausea,3,16154824
0,22.0,Malignant neoplasm progression,5,16154847
0,22.0,Inappropriate schedule of product administration,6,16154849
0,22.0,Lung neoplasm malignant,5,16154868
1,22.0,Inadequate analgesia,1,16154868
2,22.0,Metastases to central nervous system,5,16154868
3,22.0,Constipation,6,16154868
0,22.0,Death,5,16154879
0,22.0,Lymphocytosis,3,16154889
0,22.0,Ventricular fibrillation,4,16154978
0,22.0,Breast cancer metastatic,6,16154979
1,22.0,Malignant neoplasm progression,6,16154979
0,22.0,Dermatitis acneiform,1,16155024
0,22.0,Malignant neoplasm progression,3,16155059
1,22.0,Gait disturbance,1,16155059
2,22.0,Type 2 diabetes mellitus,3,16155059
3,22.0,Dyspnoea,3,16155059
4,22.0,Dizziness,1,16155059
5,22.0,Hypothyroidism,3,16155059
6,22.0,Anaemia,1,16155059
7,22.0,Fatigue,1,16155059
8,22.0,Epilepsy,3,16155059
9,22.0,Pain,3,16155059
10,22.0,Cough,1,16155059
11,22.0,Pruritus,1,16155059
12,22.0,Arthralgia,1,16155059
13,22.0,Cerebral ischaemia,3,16155059
14,22.0,Decreased appetite,1,16155059
15,22.0,Erythema,1,16155059
16,22.0,Thrombocytopenia,1,16155059
17,22.0,Off label use,6,16155059
0,22.0,Rash,6,16155067
1,22.0,Diarrhoea,6,16155067
2,22.0,Malignant neoplasm progression,6,16155067
0,22.0,Breast cancer female,3,16155101
1,22.0,Malignant neoplasm progression,3,16155101
0,22.1,Alanine aminotransferase increased,4,16155124
1,22.1,Confusional state,1,16155124
2,22.1,Aspartate aminotransferase increased,4,16155124
3,22.1,Weight decreased,3,16155124
4,22.1,Fatigue,1,16155124
5,22.1,Blood bilirubin increased,1,16155124
0,22.1,Cardio-respiratory arrest,5,16155129
1,22.1,Fatigue,6,16155129
2,22.1,Lymphocyte count decreased,6,16155129
3,22.1,Red blood cell count decreased,1,16155129
4,22.1,White blood cell count increased,1,16155129
5,22.1,Central nervous system lesion,6,16155129
6,22.1,Bacterial infection,3,16155129
7,22.1,Haematocrit decreased,1,16155129
8,22.1,Aspartate aminotransferase increased,6,16155129
9,22.1,Lymphocyte count increased,1,16155129
10,22.1,Blood thyroid stimulating hormone increased,6,16155129
11,22.1,Monocyte count increased,1,16155129
12,22.1,Blood calcium decreased,6,16155129
13,22.1,Bundle branch block left,3,16155129
14,22.1,Neutrophil count increased,1,16155129
15,22.1,Mean cell volume decreased,1,16155129
16,22.1,General physical health deterioration,6,16155129
17,22.1,Red blood cell sedimentation rate increased,1,16155129
18,22.1,Blood creatinine decreased,3,16155129
19,22.1,Haemoglobin decreased,1,16155129
20,22.1,Platelet count decreased,6,16155129
21,22.1,Alanine aminotransferase increased,6,16155129
22,22.1,Proteus infection,6,16155129
23,22.1,Asthenia,6,16155129
24,22.1,Muscular weakness,6,16155129
0,22.0,Malignant neoplasm progression,5,16155191
1,22.0,Interstitial lung disease,2,16155191
2,22.0,Chronic obstructive pulmonary disease,1,16155191
3,22.0,Dyspnoea exertional,3,16155191
4,22.0,Chest pain,3,16155191
5,22.0,Blood thyroid stimulating hormone increased,1,16155191
6,22.0,Erysipelas,6,16155191
0,22.0,Blood count abnormal,6,16155220
0,22.1,Myositis,6,16155494
1,22.1,Malignant neoplasm progression,5,16155494
2,22.1,Myasthenia gravis,3,16155494
0,22.0,Off label use,6,16155521
0,22.0,Neutrophil count decreased,1,16155537
1,22.0,Pleural effusion,3,16155537
2,22.0,Ascites,3,16155537
0,22.0,Malignant neoplasm progression,6,16155585
1,22.0,Off label use,6,16155585
2,22.0,Triple negative breast cancer,6,16155585
0,22.0,Malignant neoplasm progression,6,16155586
1,22.0,Off label use,6,16155586
2,22.0,Triple negative breast cancer,6,16155586
0,22.0,Off label use,6,16155587
1,22.0,Malignant neoplasm progression,6,16155587
2,22.0,Triple negative breast cancer,6,16155587
0,22.0,Off label use,6,16155589
1,22.0,Triple negative breast cancer,6,16155589
2,22.0,Malignant neoplasm progression,6,16155589
0,22.0,Off label use,6,16155590
1,22.0,Triple negative breast cancer,6,16155590
2,22.0,Malignant neoplasm progression,6,16155590
0,22.0,Triple negative breast cancer,6,16155591
1,22.0,Off label use,6,16155591
2,22.0,Malignant neoplasm progression,6,16155591
0,22.0,Malignant neoplasm progression,6,16155592
1,22.0,Off label use,6,16155592
2,22.0,Triple negative breast cancer,6,16155592
0,22.0,Disease progression,6,16155599
1,22.0,Colon cancer,6,16155599
2,22.0,Dermatitis acneiform,3,16155599
0,22.0,Psoriasis,3,16155654
1,22.0,Dyspnoea,6,16155654
2,22.0,Pneumonia,6,16155654
3,22.0,Immune-mediated hepatitis,2,16155654
4,22.0,Malignant neoplasm progression,3,16155654
0,22.0,Urticaria,1,16155660
1,22.0,Hypoxia,1,16155660
2,22.0,Hypotension,1,16155660
3,22.0,Malaise,1,16155660
4,22.0,Paraesthesia,1,16155660
5,22.0,Hypoaesthesia,1,16155660
0,22.0,Febrile neutropenia,1,16155730
1,22.0,Pneumonia,1,16155730
0,22.0,Osteonecrosis of jaw,3,16155754
1,22.0,Gingivitis,3,16155754
2,22.0,Fistula,3,16155754
0,22.0,Leukaemia,3,16155767
1,22.0,Neoplasm,3,16155767
2,22.0,Acute myeloid leukaemia,3,16155767
0,22.0,Shock,2,16155778
0,22.0,Product availability issue,6,16155783
1,22.0,Product dose omission,6,16155783
2,22.0,No adverse event,6,16155783
0,22.0,Disease progression,3,16155832
1,22.0,Neutropenia,6,16155832
2,22.0,Carcinoembryonic antigen increased,3,16155832
0,22.0,Adrenal disorder,3,16155836
0,22.0,Carcinoembryonic antigen increased,3,16155906
1,22.0,Malignant neoplasm progression,3,16155906
0,22.0,Pancytopenia,1,16155907
1,22.0,Thrombocytopenia,1,16155907
0,22.0,Hepatic atrophy,6,16155918
1,22.0,Hepatic function abnormal,6,16155918
2,22.0,Platelet count decreased,6,16155918
0,22.0,Mucosal inflammation,6,16155921
1,22.0,Diarrhoea,6,16155921
0,22.0,Depressed level of consciousness,6,16155956
1,22.0,Somnolence,6,16155956
0,22.0,Apnoea,6,16155958
1,22.0,Depressed level of consciousness,1,16155958
2,22.0,Somnolence,6,16155958
0,22.0,Death,5,16155963
0,22.0,Interstitial lung disease,2,16155972
0,22.0,Cholangitis sclerosing,6,16155990
1,22.0,Fulminant type 1 diabetes mellitus,6,16155990
0,22.1,Red blood cell count decreased,6,16156042
1,22.1,White blood cell count increased,6,16156042
2,22.1,Lymphocyte count decreased,6,16156042
3,22.1,White blood cell count decreased,3,16156042
4,22.1,Basophil count increased,3,16156042
5,22.1,Cerebral disorder,6,16156042
6,22.1,Monocyte count increased,1,16156042
7,22.1,Basophil count increased,1,16156042
8,22.1,Platelet count decreased,6,16156042
9,22.1,Haemoglobin decreased,3,16156042
10,22.1,Eosinophil count decreased,6,16156042
11,22.1,Neutrophil percentage increased,6,16156042
12,22.1,Monocyte percentage increased,6,16156042
13,22.1,Pancytopenia,3,16156042
14,22.1,Anaemia,6,16156042
15,22.1,Neutrophil count increased,6,16156042
16,22.1,Neutrophil count decreased,3,16156042
17,22.1,Red cell distribution width decreased,3,16156042
18,22.1,Contusion,6,16156042
19,22.1,Haematocrit decreased,6,16156042
20,22.1,Neutropenia,1,16156042
0,22.0,Back pain,1,16156097
1,22.0,Sensation of foreign body,1,16156097
2,22.0,Dyspnoea,1,16156097
3,22.0,Hot flush,1,16156097
4,22.0,Hyperaemia,1,16156097
0,22.0,Peripheral artery thrombosis,6,16156128
1,22.0,Oedema peripheral,6,16156128
2,22.0,Deep vein thrombosis,6,16156128
3,22.0,Pelvic venous thrombosis,6,16156128
0,22.0,Bone marrow failure,1,16156129
0,22.0,Peripheral swelling,2,16156145
1,22.0,Skin discolouration,2,16156145
2,22.0,International normalised ratio increased,3,16156145
3,22.0,Sensory loss,2,16156145
0,22.0,Infusion related reaction,1,16156176
1,22.0,Atrial fibrillation,3,16156176
0,22.0,Stomatitis,1,16156179
1,22.0,Neutrophil count decreased,1,16156179
2,22.0,Malaise,1,16156179
3,22.0,Paronychia,1,16156179
4,22.0,Catheter site ulcer,1,16156179
0,22.0,Nausea,1,16156236
1,22.0,Rash,1,16156236
2,22.0,Product use in unapproved indication,6,16156236
3,22.0,Pneumonia,3,16156236
4,22.0,Chills,1,16156236
5,22.0,Blood electrolytes abnormal,3,16156236
6,22.0,Vomiting,1,16156236
7,22.0,Malignant neoplasm progression,5,16156236
8,22.0,Depressed level of consciousness,1,16156236
0,22.0,Lymphocytic hypophysitis,6,16156241
1,22.0,Hypopituitarism,2,16156241
2,22.0,Respiratory disorder,6,16156241
3,22.0,Adrenocorticotropic hormone deficiency,6,16156241
0,22.0,Hyperthermia,6,16156269
1,22.0,Soft tissue necrosis,6,16156269
2,22.0,Induration,6,16156269
3,22.0,Hyperaemia,6,16156269
4,22.0,Injection site extravasation,6,16156269
0,22.0,Hepatotoxicity,3,16156279
0,22.1,Neuropathy peripheral,6,16156321
0,22.0,Bronchospasm,1,16156341
1,22.0,Respiratory failure,1,16156341
0,22.0,Nausea,1,16156345
1,22.0,Hypertension,1,16156345
2,22.0,Dyspnoea,1,16156345
3,22.0,Infusion related reaction,1,16156345
4,22.0,Back pain,1,16156345
5,22.0,Headache,1,16156345
0,22.0,Tendonitis,3,16156362
0,22.0,Confusional state,1,16156387
1,22.0,Fall,6,16156387
2,22.0,Inappropriate antidiuretic hormone secretion,2,16156387
0,22.0,Abdominal distension,1,16156449
0,22.0,Non-small cell lung cancer,5,16156482
0,22.0,Rash generalised,6,16156499
1,22.0,Product use in unapproved indication,6,16156499
2,22.0,Rash pruritic,6,16156499
0,22.0,Pneumonia,5,16156575
1,22.0,Septic shock,5,16156575
2,22.0,Blast cells present,5,16156575
3,22.0,Fournier^s gangrene,5,16156575
0,22.0,Gastrointestinal perforation,6,16156592
0,22.0,Pulmonary embolism,2,16156610
1,22.0,Cor pulmonale acute,2,16156610
2,22.0,Cardiorenal syndrome,2,16156610
0,22.1,Tubulointerstitial nephritis,6,16156612
1,22.1,Dehydration,6,16156612
0,22.0,Gingivitis,6,16156613
1,22.0,Fall,6,16156613
2,22.0,Hypoaesthesia,6,16156613
3,22.0,Thirst decreased,6,16156613
4,22.0,Chronic cheek biting,6,16156613
5,22.0,Constipation,6,16156613
6,22.0,Discomfort,2,16156613
7,22.0,Unevaluable event,2,16156613
8,22.0,Tongue biting,6,16156613
9,22.0,Feeling abnormal,6,16156613
10,22.0,Dry mouth,6,16156613
11,22.0,Seizure,6,16156613
0,22.0,Interstitial lung disease,5,16156630
0,22.0,Death,5,16156672
0,22.0,Death,5,16156719
0,22.0,Dyspepsia,2,16156732
1,22.0,Nausea,2,16156732
2,22.0,Cardiotoxicity,2,16156732
3,22.0,Chest discomfort,2,16156732
0,22.0,Vomiting,3,16156739
1,22.0,Acute kidney injury,1,16156739
2,22.0,Diarrhoea,3,16156739
0,22.0,Sepsis,5,16156758
0,22.0,Pruritus,1,16156762
1,22.0,Respiratory distress,1,16156762
2,22.0,Hypersensitivity,1,16156762
3,22.0,Rash,1,16156762
4,22.0,Off label use,6,16156762
0,22.0,Metastases to neck,2,16156768
0,22.1,Thyrotoxic crisis,1,16156794
0,22.0,Weight decreased,6,16156802
1,22.0,Metastases to central nervous system,6,16156802
2,22.0,Clostridium difficile infection,6,16156802
3,22.0,Nausea,6,16156802
4,22.0,Metastases to spine,1,16156802
5,22.0,Memory impairment,6,16156802
6,22.0,Vomiting,6,16156802
7,22.0,Vitamin D decreased,6,16156802
8,22.0,Dermatitis allergic,6,16156802
9,22.0,Blood calcium decreased,6,16156802
0,22.1,Abdominal pain,6,16156813
1,22.1,Oedema peripheral,6,16156813
2,22.1,Liver function test increased,3,16156813
3,22.1,Mobility decreased,2,16156813
4,22.1,Fatigue,6,16156813
5,22.1,Spinal pain,2,16156813
6,22.1,Nausea,6,16156813
0,22.0,Dysarthria,6,16156857
1,22.0,Asthenia,6,16156857
2,22.0,Fatigue,6,16156857
3,22.0,Confusional state,6,16156857
4,22.0,Abdominal distension,6,16156857
5,22.0,Ammonia increased,6,16156857
6,22.0,Mobility decreased,6,16156857
7,22.0,Decreased appetite,6,16156857
8,22.0,Dehydration,6,16156857
9,22.0,Hepatic cirrhosis,6,16156857
0,22.0,Mass,3,16156862
0,22.0,Pancreatitis,6,16156930
1,22.0,Sinus tachycardia,6,16156930
2,22.0,Type 1 diabetes mellitus,2,16156930
3,22.0,Xanthopsia,1,16156930
4,22.0,Weight increased,6,16156930
5,22.0,Hiccups,6,16156930
6,22.0,Graft versus host disease in gastrointestinal tract,1,16156930
7,22.0,Hepatic steatosis,6,16156930
8,22.0,Diabetic ketoacidosis,1,16156930
9,22.0,Haematocrit decreased,6,16156930
10,22.0,Platelet count decreased,6,16156930
11,22.0,Hypertension,6,16156930
0,22.0,Diarrhoea,6,16156931
0,22.0,Non-small cell lung cancer,5,16156943
0,22.0,Death,5,16156944
0,22.0,Death,5,16157005
0,22.0,Livedo reticularis,3,16157052
1,22.0,Pelvic pain,3,16157052
2,22.0,Malaise,3,16157052
0,22.0,Disease progression,6,16157065
0,22.0,Disease progression,6,16157102
0,22.0,Colon cancer metastatic,5,16157103
0,22.0,Hepatocellular injury,1,16157106
0,22.0,Peripheral venous disease,5,16157129
0,22.0,Bicytopenia,1,16157147
1,22.0,Thrombocytopenia,1,16157147
0,22.0,General physical health deterioration,6,16157193
0,22.0,Diarrhoea,,16157297
1,22.0,Pain in extremity,,16157297
0,22.0,Decreased appetite,,16157308
0,22.0,Renal cancer metastatic,5,16157328
1,22.0,Aphthous ulcer,4,16157328
2,22.0,Malignant neoplasm progression,5,16157328
3,22.0,Flatulence,1,16157328
4,22.0,Aspartate aminotransferase increased,1,16157328
5,22.0,Headache,1,16157328
0,22.0,Cerebral artery thrombosis,5,16157352
1,22.0,Arteriosclerosis,5,16157352
2,22.0,Subendocardial ischaemia,5,16157352
3,22.0,Idiopathic pulmonary fibrosis,5,16157352
4,22.0,Interstitial lung disease,6,16157352
5,22.0,Staphylococcus test positive,6,16157352
6,22.0,Brain oedema,5,16157352
7,22.0,Malignant neoplasm progression,5,16157352
0,22.1,Cardiomyopathy,3,16157370
1,22.1,Mitral valve disease,2,16157370
2,22.1,General physical health deterioration,6,16157370
3,22.1,Diarrhoea,1,16157370
4,22.1,Pulmonary hypertension,1,16157370
0,22.0,Ascites,6,16157371
0,22.1,Hot flush,6,16157398
1,22.1,Anxiety,6,16157398
2,22.1,Pulse abnormal,6,16157398
3,22.1,Chest pain,6,16157398
4,22.1,Gingival bleeding,1,16157398
5,22.1,Blood pressure increased,6,16157398
6,22.1,Palpitations,6,16157398
0,22.1,Asthenia,6,16157429
1,22.1,Dysarthria,6,16157429
2,22.1,Speech disorder,6,16157429
3,22.1,Yellow skin,6,16157429
4,22.1,Overdose,6,16157429
5,22.1,Gait disturbance,6,16157429
6,22.1,Pain,6,16157429
7,22.1,Chromaturia,6,16157429
8,22.1,Dehydration,6,16157429
9,22.1,Weight decreased,6,16157429
10,22.1,Coordination abnormal,6,16157429
11,22.1,Anal incontinence,6,16157429
12,22.1,Jaundice,6,16157429
13,22.1,Diarrhoea,6,16157429
14,22.1,Death,5,16157429
15,22.1,Flatulence,6,16157429
16,22.1,Haemorrhage,6,16157429
17,22.1,Dysstasia,6,16157429
18,22.1,Hepatic function abnormal,6,16157429
19,22.1,Feeling cold,6,16157429
20,22.1,Cerebrovascular accident,6,16157429
21,22.1,Neoplasm progression,6,16157429
22,22.1,Abdominal pain upper,6,16157429
0,22.0,Neoplasm progression,6,16157469
1,22.0,Product use in unapproved indication,6,16157469
0,22.0,Menopause,6,16157486
0,22.0,Hair colour changes,3,16157500
1,22.0,Alopecia,3,16157500
2,22.0,Madarosis,3,16157500
3,22.0,Hair texture abnormal,3,16157500
4,22.0,Hair disorder,3,16157500
0,22.0,Madarosis,3,16157522
1,22.0,Alopecia,3,16157522
2,22.0,Depression,6,16157522
3,22.0,Hair disorder,3,16157522
4,22.0,Hair colour changes,3,16157522
5,22.0,Hair texture abnormal,3,16157522
0,22.1,Influenza like illness,1,16157540
0,22.0,Nasopharyngitis,6,16157549
1,22.0,Neutropenia,6,16157549
0,22.0,Malignant neoplasm progression,6,16157588
0,22.0,Therapy cessation,,16157595
1,22.0,Hospitalisation,,16157595
0,22.0,Death,5,16157716
1,22.0,Prostate cancer,6,16157716
2,22.0,Gastrointestinal viral infection,6,16157716
0,22.0,Prostatic specific antigen increased,6,16157718
1,22.0,Drug ineffective,6,16157718
2,22.0,Haematuria,6,16157718
3,22.0,Haemorrhage subcutaneous,6,16157718
4,22.0,Dysuria,6,16157718
0,22.0,Acute myocardial infarction,6,16157749
1,22.0,Aortic valve incompetence,6,16157749
2,22.0,Tricuspid valve incompetence,6,16157749
3,22.0,Left ventricular dysfunction,6,16157749
4,22.0,Cardiomyopathy,2,16157749
5,22.0,Aortic arteriosclerosis,6,16157749
6,22.0,Cardiac failure congestive,6,16157749
7,22.0,Cardiomegaly,6,16157749
8,22.0,Sinus tachycardia,6,16157749
9,22.0,Myocarditis,6,16157749
0,22.0,Fall,6,16157843
1,22.0,Psoriasis,6,16157843
2,22.0,Back pain,6,16157843
3,22.0,Weight decreased,6,16157843
4,22.0,Choking sensation,6,16157843
5,22.0,Asthenia,6,16157843
6,22.0,Fatigue,6,16157843
7,22.0,Stomatitis,6,16157843
8,22.0,Diarrhoea,6,16157843
9,22.0,Corneal oedema,6,16157843
10,22.0,Back pain,6,16157843
11,22.0,Haematuria,6,16157843
12,22.0,Fatigue,6,16157843
13,22.0,Ageusia,6,16157843
14,22.0,Asthenia,6,16157843
15,22.0,Oedema peripheral,6,16157843
16,22.0,Decreased appetite,6,16157843
17,22.0,Cough,6,16157843
18,22.0,Fatigue,6,16157843
19,22.0,Visual impairment,6,16157843
20,22.0,Decreased appetite,6,16157843
21,22.0,Cough,6,16157843
22,22.0,Stomatitis,6,16157843
0,22.0,Hypertension,1,16157844
1,22.0,Back pain,1,16157844
2,22.0,Dyspnoea,1,16157844
3,22.0,Headache,1,16157844
4,22.0,Infusion related reaction,1,16157844
5,22.0,Nausea,1,16157844
0,22.0,Thrombocytopenia,3,16157869
0,22.0,Metastases to spleen,1,16157905
1,22.0,Malignant neoplasm progression,1,16157905
0,22.0,Haematological malignancy,6,16157910
1,22.0,Tumour marker abnormal,2,16157910
2,22.0,Metastases to lung,2,16157910
0,22.0,Radiation skin injury,1,16157994
0,22.0,Pleural effusion,6,16158008
1,22.0,Respiratory failure,6,16158008
2,22.0,Cardiac failure,6,16158008
3,22.0,Chronic obstructive pulmonary disease,1,16158008
4,22.0,Neutropenia,6,16158008
5,22.0,Dyspnoea exertional,6,16158008
0,22.0,Metastases to central nervous system,6,16158073
1,22.0,Asthenia,2,16158073
0,22.0,Acute lymphocytic leukaemia,3,16158077
0,22.0,Proteinuria,6,16158121
1,22.0,Renal failure,3,16158121
2,22.0,Medication error,6,16158121
3,22.0,End stage renal disease,3,16158121
4,22.0,Malignant neoplasm progression,5,16158121
5,22.0,Hypoproteinaemia,6,16158121
6,22.0,Glomerulonephritis,6,16158121
7,22.0,Blood pressure decreased,6,16158121
8,22.0,Thrombocytopenia,1,16158121
9,22.0,Thrombotic microangiopathy,3,16158121
10,22.0,Blood lactate dehydrogenase increased,6,16158121
11,22.0,Vomiting,6,16158121
12,22.0,Anaemia,6,16158121
13,22.0,Microangiopathic haemolytic anaemia,1,16158121
14,22.0,Hyperkalaemia,6,16158121
0,22.0,Haematochezia,1,16158194
1,22.0,Blood urine present,1,16158194
0,22.0,Neutropenia,6,16158205
1,22.0,White blood cell count decreased,6,16158205
2,22.0,Full blood count decreased,6,16158205
0,22.1,Platelet count decreased,6,16158223
1,22.1,Vomiting,6,16158223
2,22.1,Fatigue,6,16158223
3,22.1,Second primary malignancy,6,16158223
4,22.1,Hepatic cancer,6,16158223
5,22.1,Rhinorrhoea,6,16158223
6,22.1,Hypersensitivity,6,16158223
7,22.1,Pain in extremity,6,16158223
8,22.1,Pruritus,6,16158223
9,22.1,Arthralgia,6,16158223
0,22.0,Diarrhoea,6,16158246
1,22.0,Asthenia,6,16158246
2,22.0,Vision blurred,6,16158246
3,22.0,Anaemia,6,16158246
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16158246
5,22.0,Respiratory failure,6,16158246
6,22.0,Mucosal inflammation,6,16158246
0,22.0,Blood urine present,3,16158258
0,22.0,Blood test abnormal,6,16158259
1,22.0,Death,5,16158259
0,22.0,Death,,16158288
0,22.0,Nausea,6,16158289
1,22.0,Abdominal pain,6,16158289
2,22.0,Vomiting,6,16158289
3,22.0,Constipation,6,16158289
4,22.0,Subileus,6,16158289
5,22.0,Hyperpyrexia,1,16158289
6,22.0,Granulocyte count decreased,2,16158289
0,22.0,Product prescribing error,6,16158360
1,22.0,White blood cell count decreased,6,16158360
0,22.0,Dry skin,,16158369
1,22.0,Rash,,16158369
0,22.0,Electrocardiogram QT prolonged,1,16158402
0,22.0,Full blood count decreased,,16158403
0,22.0,Deep vein thrombosis,6,16158441
0,22.0,Fall,6,16158461
1,22.0,Platelet count decreased,6,16158461
2,22.0,Skin irritation,6,16158461
3,22.0,Nasopharyngitis,6,16158461
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16158461
5,22.0,Nausea,1,16158461
6,22.0,Pain in extremity,3,16158461
7,22.0,Pyrexia,1,16158461
8,22.0,Blister,6,16158461
9,22.0,Dry mouth,6,16158461
10,22.0,Musculoskeletal pain,6,16158461
11,22.0,Oral pain,6,16158461
12,22.0,Faeces discoloured,6,16158461
13,22.0,Product use in unapproved indication,6,16158461
14,22.0,Vision blurred,3,16158461
15,22.0,Dyspepsia,6,16158461
16,22.0,Peripheral swelling,6,16158461
17,22.0,Poor quality sleep,3,16158461
18,22.0,Flatulence,6,16158461
19,22.0,Dyspnoea,6,16158461
20,22.0,Hypertension,6,16158461
21,22.0,Cow^s milk intolerance,6,16158461
22,22.0,Burning sensation,3,16158461
23,22.0,Abdominal pain lower,1,16158461
24,22.0,Vomiting,6,16158461
25,22.0,Headache,1,16158461
26,22.0,Hunger,6,16158461
27,22.0,Tongue discomfort,6,16158461
28,22.0,Back pain,6,16158461
29,22.0,Depressed mood,6,16158461
30,22.0,Rash,6,16158461
31,22.0,Diarrhoea,6,16158461
32,22.0,Sleep disorder,6,16158461
33,22.0,Intestinal transit time abnormal,3,16158461
34,22.0,Weight decreased,1,16158461
35,22.0,Breast pain,6,16158461
36,22.0,Off label use,6,16158461
37,22.0,Erythema,6,16158461
38,22.0,Salivary gland cancer stage IV,6,16158461
39,22.0,Mucosal inflammation,6,16158461
40,22.0,Hypermetropia,6,16158461
41,22.0,Muscle spasms,6,16158461
42,22.0,Fatigue,3,16158461
43,22.0,Alopecia,3,16158461
44,22.0,Abdominal pain,1,16158461
45,22.0,Gastrointestinal pain,6,16158461
46,22.0,Decreased appetite,3,16158461
0,22.0,Disease progression,,16158462
0,22.0,Electrocardiogram abnormal,1,16158492
1,22.0,Acute myocardial infarction,1,16158492
0,22.0,Death,5,16158503
0,22.0,Insomnia,6,16158595
0,22.0,Full blood count decreased,6,16158599
0,22.0,Metastases to liver,6,16158604
1,22.0,Malignant neoplasm progression,6,16158604
2,22.0,Rectal cancer metastatic,6,16158604
3,22.0,Metastases to lung,6,16158604
0,22.0,Death,5,16158655
0,22.0,Bladder obstruction,6,16158672
1,22.0,Haemorrhage,6,16158672
2,22.0,Renal disorder,6,16158672
0,22.0,Cerebrovascular accident,1,16158674
1,22.0,Thrombocytopenia,1,16158674
0,22.0,Death,5,16158675
1,22.0,Drug ineffective,6,16158675
0,22.0,Malignant neoplasm progression,5,16158691
1,22.0,Abdominal distension,5,16158691
2,22.0,Onychoclasis,6,16158691
3,22.0,Carbohydrate antigen 125 increased,6,16158691
4,22.0,Constipation,5,16158691
5,22.0,Neuropathy peripheral,3,16158691
6,22.0,Decreased appetite,5,16158691
7,22.0,General physical health deterioration,6,16158691
8,22.0,Metastases to peritoneum,5,16158691
0,22.0,Death,,16158699
0,22.0,Influenza like illness,1,16158707
1,22.0,Cystitis,1,16158707
2,22.0,Mucosal inflammation,1,16158707
3,22.0,Mucosal inflammation,1,16158707
4,22.0,Blister infected,1,16158707
0,22.0,Abdominal pain upper,6,16158708
1,22.0,Nausea,6,16158708
2,22.0,Vomiting,6,16158708
3,22.0,Odynophagia,6,16158708
4,22.0,Neoplasm progression,6,16158708
0,22.0,Stevens-Johnson syndrome,1,16158712
1,22.0,Pneumonia,1,16158712
2,22.0,Stomatitis,1,16158712
3,22.0,Rash,1,16158712
4,22.0,Urine output decreased,6,16158712
0,22.0,Death,5,16158810
0,22.0,Hormone-refractory prostate cancer,3,16158841
1,22.0,Bone pain,3,16158841
0,22.0,Hormone-refractory prostate cancer,5,16158854
1,22.0,Bone pain,3,16158854
0,22.0,Transient ischaemic attack,6,16158863
0,22.0,Death,,16158894
0,22.0,Cytopenia,6,16158998
0,22.0,Malignant neoplasm progression,6,16159000
1,22.0,Breast cancer,6,16159000
0,22.0,Metastases to bone,6,16159001
0,22.0,Death,5,16159043
0,22.0,Psychotic disorder,1,16159048
1,22.0,Posterior reversible encephalopathy syndrome,2,16159048
0,22.0,Wheezing,3,16159051
1,22.0,Pneumonitis,3,16159051
0,22.0,Myalgia,2,16159091
1,22.0,Guillain-Barre syndrome,2,16159091
2,22.0,Peripheral venous disease,2,16159091
3,22.0,Polyneuropathy,2,16159091
0,22.0,Feeding disorder,6,16159129
1,22.0,Intestinal obstruction,5,16159129
0,22.0,Electrocardiogram QT prolonged,1,16159152
1,22.0,Nausea,1,16159152
2,22.0,Decreased appetite,1,16159152
3,22.0,Bradycardia,1,16159152
4,22.0,Metastases to lung,3,16159152
5,22.0,Drug ineffective,6,16159152
6,22.0,Malignant neoplasm progression,3,16159152
7,22.0,Electrocardiogram QT prolonged,1,16159152
8,22.0,Non-small cell lung cancer stage IV,3,16159152
9,22.0,C-reactive protein increased,3,16159152
10,22.0,Decreased appetite,1,16159152
11,22.0,Malignant pleural effusion,3,16159152
12,22.0,Gastroenteritis,1,16159152
0,22.0,Pruritus,6,16159195
1,22.0,Rash,1,16159195
2,22.0,Urticaria,1,16159195
0,22.0,Neck pain,6,16159215
1,22.0,Ear pain,6,16159215
0,22.0,Myalgia,2,16159222
1,22.0,Polyneuropathy,2,16159222
2,22.0,Guillain-Barre syndrome,2,16159222
3,22.0,Peripheral venous disease,2,16159222
0,22.0,Platelet count decreased,2,16159223
1,22.0,Stomatitis,2,16159223
2,22.0,Fatigue,2,16159223
3,22.0,Dermatitis,2,16159223
4,22.0,Malignant neoplasm progression,6,16159223
5,22.0,Alopecia,2,16159223
0,22.0,Pain,1,16159225
1,22.0,Mucosal inflammation,1,16159225
0,22.0,Body temperature decreased,1,16159228
1,22.0,Malaise,1,16159228
2,22.0,Blood magnesium decreased,1,16159228
0,22.0,Pancytopenia,4,16159238
1,22.0,Febrile neutropenia,1,16159238
2,22.0,Stomatitis,1,16159238
3,22.0,Rash,1,16159238
0,22.0,Blood pressure increased,1,16159239
1,22.0,Tachycardia,1,16159239
2,22.0,Blood pressure decreased,1,16159239
3,22.0,Dyspnoea,1,16159239
4,22.0,Body temperature increased,1,16159239
5,22.0,Chills,1,16159239
6,22.0,Erythema,1,16159239
7,22.0,Malaise,1,16159239
0,22.0,Road traffic accident,1,16159240
1,22.0,Upper limb fracture,1,16159240
2,22.0,Limb injury,3,16159240
0,22.0,General physical health deterioration,1,16159242
1,22.0,Large intestine perforation,4,16159242
0,22.0,Death,5,16159256
0,22.0,Bronchospasm,1,16159280
1,22.0,Respiratory failure,1,16159280
0,22.0,Drug ineffective,6,16159281
1,22.0,Hepatotoxicity,6,16159281
0,22.0,Tachyarrhythmia,1,16159282
0,22.0,Thrombocytopenia,5,16159283
1,22.0,Condition aggravated,5,16159283
0,22.0,Dermatitis acneiform,3,16159293
1,22.0,Stomatitis,2,16159293
0,22.0,Inappropriate schedule of product administration,6,16159376
1,22.0,Ascites,6,16159376
2,22.0,Product use in unapproved indication,6,16159376
3,22.0,Adverse event,6,16159376
4,22.0,Adverse event,6,16159376
0,22.0,Cholecystitis,3,16159388
0,22.1,Hormone-refractory prostate cancer,5,16159415
1,22.1,Off label use,6,16159415
2,22.1,Product use in unapproved indication,6,16159415
0,22.0,Colon cancer,5,16159494
0,22.0,Death,5,16159495
1,22.0,Coma,6,16159495
0,22.0,Alopecia,2,16159555
1,22.0,Psychological trauma,6,16159555
0,22.0,Photosensitivity reaction,6,16159744
0,22.1,Malnutrition,5,16159770
1,22.1,Performance status decreased,5,16159770
2,22.1,Pharyngeal inflammation,6,16159770
3,22.1,Cardiac failure,5,16159770
4,22.1,Dysphagia,6,16159770
5,22.1,Pneumonia aspiration,5,16159770
0,22.0,Malignant neoplasm progression,5,16159778
1,22.0,Pneumonia,5,16159778
0,22.0,Death,5,16159814
0,22.0,Acute kidney injury,2,16159840
0,22.0,Product use in unapproved indication,6,16159873
1,22.0,Therapeutic response unexpected,6,16159873
0,22.0,Product use in unapproved indication,6,16159938
1,22.0,Adverse event,6,16159938
2,22.0,Transfusion,6,16159938
0,22.0,Death,5,16159983
0,22.0,Lung disorder,6,16159984
1,22.0,Rash,3,16159984
2,22.0,Skin lesion,3,16159984
3,22.0,Skin haemorrhage,1,16159984
0,22.0,Death,5,16159997
1,22.0,Off label use,6,16159997
0,22.0,Rhabdomyolysis,2,16160033
0,22.0,Fatigue,6,16160112
0,22.0,Feeling hot,1,16160124
1,22.0,Dizziness,1,16160124
2,22.0,Infusion related reaction,1,16160124
3,22.0,Anaphylactic reaction,1,16160124
4,22.0,Erythema,1,16160124
0,22.0,Pneumonia,6,16160135
1,22.0,Pulmonary oedema,6,16160135
2,22.0,Oxygen consumption decreased,5,16160135
0,22.0,Retching,3,16160256
1,22.0,Insomnia,2,16160256
2,22.0,Cough,2,16160256
3,22.0,Carbohydrate antigen 125 increased,3,16160256
4,22.0,Nasopharyngitis,3,16160256
5,22.0,Nausea,3,16160256
6,22.0,Disease progression,6,16160256
7,22.0,Sinus disorder,6,16160256
8,22.0,Pneumonia,3,16160256
9,22.0,Blood pressure increased,6,16160256
10,22.0,Wound,1,16160256
0,22.0,Hunger,6,16160343
1,22.0,Constipation,6,16160343
2,22.0,Fluid retention,2,16160343
3,22.0,Abdominal distension,6,16160343
0,22.0,Anaemia,6,16160347
1,22.0,Tumour haemorrhage,6,16160347
2,22.0,Haemoptysis,5,16160347
3,22.0,Malignant neoplasm progression,6,16160347
4,22.0,Thrombocytopenia,5,16160347
5,22.0,Haematuria,5,16160347
6,22.0,Laryngeal oedema,6,16160347
0,22.0,Crohn^s disease,3,16160351
0,22.0,White blood cell count decreased,1,16160409
0,22.0,Diplopia,6,16160413
1,22.0,VIth nerve paralysis,6,16160413
0,22.0,Triple negative breast cancer,6,16160420
1,22.0,Malignant neoplasm progression,6,16160420
2,22.0,Off label use,6,16160420
0,22.0,Triple negative breast cancer,6,16160427
1,22.0,Off label use,6,16160427
2,22.0,Malignant neoplasm progression,6,16160427
0,22.0,Haemoglobin decreased,3,16160441
1,22.0,Ascites,3,16160441
2,22.0,Abscess,5,16160441
3,22.0,Wound infection,3,16160441
4,22.0,Haemorrhage,6,16160441
5,22.0,Faecaloma,1,16160441
6,22.0,Faecaloma,1,16160441
7,22.0,Subileus,1,16160441
8,22.0,Wound haemorrhage,3,16160441
9,22.0,Pyrexia,3,16160441
10,22.0,Anaemia,6,16160441
11,22.0,Delirium,6,16160441
12,22.0,Hypertension,3,16160441
13,22.0,Proctalgia,3,16160441
0,22.0,Weight decreased,6,16160499
1,22.0,Product use in unapproved indication,6,16160499
2,22.0,Fatigue,6,16160499
0,22.0,Myalgia,2,16160527
1,22.0,Gait disturbance,6,16160527
2,22.0,Headache,2,16160527
3,22.0,Asthenia,3,16160527
4,22.0,Pain in extremity,6,16160527
5,22.0,Feeling of body temperature change,2,16160527
6,22.0,Dehydration,6,16160527
7,22.0,Skin mass,6,16160527
8,22.0,Back pain,3,16160527
9,22.0,Laryngeal oedema,6,16160527
10,22.0,Vomiting,6,16160527
11,22.0,Decreased appetite,3,16160527
12,22.0,Blood glucose increased,6,16160527
13,22.0,Back pain,3,16160527
14,22.0,Arthralgia,2,16160527
15,22.0,Aphthous ulcer,6,16160527
16,22.0,Diarrhoea,6,16160527
17,22.0,Anxiety,2,16160527
18,22.0,Blood pressure fluctuation,6,16160527
19,22.0,Joint stiffness,3,16160527
20,22.0,Musculoskeletal pain,2,16160527
21,22.0,Blood pressure increased,2,16160527
22,22.0,Musculoskeletal stiffness,3,16160527
23,22.0,Cataract,6,16160527
24,22.0,Glaucoma,6,16160527
25,22.0,Constipation,3,16160527
26,22.0,Fatigue,3,16160527
27,22.0,Swelling face,6,16160527
28,22.0,Nausea,2,16160527
29,22.0,Dyspnoea,3,16160527
30,22.0,Depression,6,16160527
31,22.0,Initial insomnia,6,16160527
32,22.0,Hypersomnia,2,16160527
33,22.0,Retching,3,16160527
34,22.0,Weight decreased,3,16160527
0,22.0,Death,5,16160636
0,22.0,Tumour marker increased,6,16160669
0,22.0,Drug ineffective,6,16160676
1,22.0,Disease progression,6,16160676
2,22.0,Skin disorder,6,16160676
0,22.0,Malaise,1,16160711
1,22.0,Dehydration,1,16160711
2,22.0,Decreased appetite,6,16160711
3,22.0,Constipation,3,16160711
4,22.0,Nausea,1,16160711
5,22.0,Diarrhoea,1,16160711
6,22.0,Acute kidney injury,1,16160711
7,22.0,Vomiting,1,16160711
8,22.0,Asthenia,6,16160711
0,22.0,Neuropathy peripheral,6,16160718
0,22.0,Pneumonitis,5,16160730
1,22.0,Febrile neutropenia,5,16160730
2,22.0,Pneumonia,5,16160730
3,22.0,Respiratory failure,5,16160730
0,22.1,Gastric disorder,1,16160755
1,22.1,Eructation,6,16160755
2,22.1,Haemorrhagic erosive gastritis,1,16160755
3,22.1,Decreased appetite,6,16160755
0,22.0,Malignant neoplasm progression,6,16160779
1,22.0,Decreased immune responsiveness,6,16160779
2,22.0,Heart rate increased,6,16160779
3,22.0,Breast cancer metastatic,6,16160779
4,22.0,Pain,6,16160779
5,22.0,Malaise,6,16160779
6,22.0,Therapeutic product effect incomplete,6,16160779
0,22.0,Cerebrovascular accident,1,16160788
1,22.0,Dyspnoea,2,16160788
2,22.0,Behaviour disorder,6,16160788
3,22.0,Gout,1,16160788
4,22.0,Cardiac failure,2,16160788
5,22.0,Pulmonary oedema,2,16160788
0,22.0,Renal cyst,6,16160856
1,22.0,Hepatic function abnormal,2,16160856
2,22.0,Computerised tomogram abnormal,6,16160856
3,22.0,Pyelonephritis,6,16160856
4,22.0,Hiccups,6,16160856
5,22.0,Emphysema,6,16160856
0,22.0,Subileus,1,16160872
0,22.0,Thrombocytopenia,3,16160888
0,22.0,Intracranial pressure increased,5,16160909
0,22.0,Lymphadenopathy,6,16160997
1,22.0,Pneumonia,3,16160997
0,22.0,Thrombocytopenia,2,16161005
0,22.0,Leukopenia,1,16161044
1,22.0,Nausea,1,16161044
2,22.0,Thrombocytopenia,1,16161044
3,22.0,Constipation,2,16161044
0,22.0,Interstitial lung disease,6,16161062
0,22.0,Fatigue,3,16161077
1,22.0,Taste disorder,1,16161077
2,22.0,Nausea,3,16161077
3,22.0,Spinal pain,1,16161077
4,22.0,Constipation,4,16161077
5,22.0,Arthralgia,1,16161077
6,22.0,Onychoclasis,1,16161077
7,22.0,Migraine,1,16161077
8,22.0,Vomiting,3,16161077
9,22.0,Neutrophil count abnormal,1,16161077
10,22.0,Bone pain,1,16161077
11,22.0,Myalgia,1,16161077
0,22.0,Fall,6,16161084
0,22.0,Pancreatitis,6,16161172
1,22.0,Type 2 diabetes mellitus,6,16161172
0,22.0,Renal disorder,2,16161178
1,22.0,IgA nephropathy,6,16161178
0,22.0,Hyperhidrosis,3,16161201
1,22.0,Hot flush,3,16161201
0,22.0,Cerebral infarction,6,16161207
1,22.0,Trousseau^s syndrome,3,16161207
2,22.0,Malignant neoplasm progression,5,16161207
0,22.0,Back pain,6,16161216
1,22.0,Irritability,6,16161216
2,22.0,Oedema peripheral,2,16161216
3,22.0,Renal impairment,6,16161216
0,22.0,Urosepsis,3,16161221
1,22.0,Bone pain,3,16161221
2,22.0,Polyneuropathy,3,16161221
3,22.0,Dyspnoea exertional,3,16161221
4,22.0,Vomiting,3,16161221
5,22.0,Acute kidney injury,3,16161221
6,22.0,Fall,3,16161221
7,22.0,Cardiac failure,6,16161221
8,22.0,Dizziness,3,16161221
9,22.0,Urinary tract infection,3,16161221
0,22.0,Musculoskeletal discomfort,3,16161223
1,22.0,Alopecia,3,16161223
2,22.0,Blood pressure increased,1,16161223
0,22.0,Peripheral swelling,1,16161318
1,22.0,Arthralgia,6,16161318
0,22.0,Tachyarrhythmia,1,16161344
0,22.0,Cerebrovascular accident,4,16161352
1,22.0,Encephalopathy,6,16161352
0,22.0,Neuropathy peripheral,6,16161420
0,22.0,Colitis,6,16161482
0,22.0,Neutropenia,6,16161528
1,22.0,Decreased appetite,6,16161528
2,22.0,Weight decreased,6,16161528
3,22.0,Rash generalised,6,16161528
4,22.0,Nausea,6,16161528
5,22.0,Diarrhoea,6,16161528
6,22.0,Pruritus,6,16161528
7,22.0,Mucosal inflammation,6,16161528
0,22.0,Guillain-Barre syndrome,2,16161537
1,22.0,Myalgia,2,16161537
2,22.0,Peripheral venous disease,2,16161537
3,22.0,Polyneuropathy,2,16161537
0,22.0,Hirsutism,3,16161544
0,22.0,Breast cancer,6,16161548
1,22.0,Metastases to bone,6,16161548
2,22.0,Metastases to lymph nodes,6,16161548
3,22.0,Malignant neoplasm progression,6,16161548
0,22.0,Haemolytic uraemic syndrome,5,16161589
1,22.0,Disease progression,5,16161589
0,22.0,Osteoporosis,3,16161592
1,22.0,Muscle spasms,3,16161592
2,22.0,Hypertension,6,16161592
3,22.0,Vulvovaginal candidiasis,6,16161592
4,22.0,Blood pressure fluctuation,3,16161592
5,22.0,Tooth extraction,6,16161592
6,22.0,Dry mouth,6,16161592
7,22.0,Pain,3,16161592
8,22.0,Osteoarthritis,6,16161592
9,22.0,Tooth demineralisation,3,16161592
10,22.0,Diabetes mellitus,3,16161592
11,22.0,Lymphoedema,3,16161592
12,22.0,Toothache,6,16161592
13,22.0,Myalgia,6,16161592
14,22.0,Eye pain,6,16161592
15,22.0,Oral candidiasis,6,16161592
16,22.0,Arthralgia,6,16161592
17,22.0,Peripheral swelling,3,16161592
18,22.0,Fatigue,3,16161592
19,22.0,Tooth infection,6,16161592
20,22.0,Nipple pain,6,16161592
21,22.0,Headache,6,16161592
22,22.0,Pain in extremity,6,16161592
23,22.0,Sensory disturbance,3,16161592
0,22.0,Potentiating drug interaction,6,16161593
1,22.0,Nervous system disorder,1,16161593
0,22.0,Interstitial lung disease,5,16161652
1,22.0,Pulmonary fibrosis,5,16161652
0,22.0,Nervous system disorder,1,16161737
1,22.0,Bacterial vaginosis,3,16161737
2,22.0,Fatigue,6,16161737
3,22.0,Product dose omission,6,16161737
4,22.0,Vomiting,1,16161737
5,22.0,Decreased immune responsiveness,3,16161737
0,22.0,Product use in unapproved indication,6,16161748
1,22.0,Oedema peripheral,1,16161748
2,22.0,Arthralgia,1,16161748
3,22.0,Off label use,6,16161748
4,22.0,Pain in extremity,1,16161748
0,22.1,Cough,6,16161816
1,22.1,Fatigue,3,16161816
2,22.1,Decreased appetite,3,16161816
3,22.1,Oropharyngeal pain,6,16161816
0,22.0,Neoplasm progression,6,16161819
0,22.0,Dry skin,3,16161823
1,22.0,Weight decreased,3,16161823
2,22.0,White blood cell count increased,3,16161823
3,22.0,Red blood cell count abnormal,3,16161823
0,22.0,Pneumonia,5,16161827
0,22.0,Death,5,16161833
0,22.0,Product prescribing error,6,16161874
1,22.0,Inappropriate schedule of product administration,6,16161874
2,22.0,Interstitial lung disease,6,16161874
0,22.0,Metastases to bone,6,16161876
0,22.0,Cerebral infarction,1,16161878
0,22.0,Diarrhoea,1,16161887
1,22.0,Vomiting,1,16161887
0,22.0,Interstitial lung disease,3,16161891
1,22.0,Colon cancer,6,16161891
2,22.0,Disease progression,6,16161891
0,22.0,Peliosis hepatis,1,16161892
0,22.0,Urinary tract infection,2,16161920
1,22.0,Hydronephrosis,6,16161920
2,22.0,Malignant neoplasm progression,5,16161920
3,22.0,Bacteraemia,2,16161920
0,22.0,Speech disorder,6,16161939
1,22.0,Loss of consciousness,2,16161939
2,22.0,Facial paresis,2,16161939
3,22.0,Weight decreased,6,16161939
4,22.0,Nausea,6,16161939
5,22.0,Epilepsy,2,16161939
6,22.0,Thrombocytopenia,1,16161939
7,22.0,Gait disturbance,6,16161939
0,22.0,Stress cardiomyopathy,2,16161949
0,22.0,Anaemia,1,16161960
1,22.0,Bicytopenia,1,16161960
2,22.0,Febrile neutropenia,1,16161960
3,22.0,Diarrhoea,1,16161960
0,22.0,Asthenia,3,16161962
1,22.0,Pelvic pain,3,16161962
2,22.0,Diarrhoea,3,16161962
3,22.0,Vomiting,3,16161962
0,22.0,Mouth ulceration,3,16161967
0,22.0,Abdominal pain,3,16161972
1,22.0,Pyrexia,3,16161972
2,22.0,Decreased appetite,3,16161972
3,22.0,Mucosal inflammation,3,16161972
4,22.0,Depression,3,16161972
5,22.0,Pyrexia,3,16161972
6,22.0,Oesophagitis,3,16161972
7,22.0,Anxiety,3,16161972
8,22.0,Dyspnoea,3,16161972
9,22.0,Anxiety,3,16161972
10,22.0,Somnolence,3,16161972
11,22.0,Fatigue,3,16161972
12,22.0,Neutropenia,3,16161972
13,22.0,Diarrhoea,6,16161972
14,22.0,Colitis,3,16161972
15,22.0,Nausea,3,16161972
16,22.0,Anaemia,3,16161972
17,22.0,Rash,3,16161972
18,22.0,Pain,3,16161972
19,22.0,Urinary tract infection,3,16161972
0,22.1,Oral candidiasis,1,16161976
1,22.1,Grip strength decreased,3,16161976
2,22.1,Urinary tract infection,1,16161976
3,22.1,Pain in extremity,3,16161976
4,22.1,General physical condition abnormal,1,16161976
5,22.1,Febrile neutropenia,1,16161976
6,22.1,Asthenia,1,16161976
7,22.1,Dizziness,3,16161976
8,22.1,Muscle spasms,3,16161976
9,22.1,Pneumonia,1,16161976
10,22.1,Dehydration,1,16161976
0,22.0,Anaphylactic reaction,1,16162031
0,22.0,Pneumonia,1,16162042
0,22.0,Drug hypersensitivity,6,16162075
0,22.0,Diarrhoea,6,16162092
0,22.0,Neoplasm progression,5,16162146
0,22.0,Wound dehiscence,3,16162150
1,22.0,Renal failure,5,16162150
0,22.0,Uterine cancer,6,16162173
0,22.0,Dizziness,6,16162215
1,22.0,Vasculitis,4,16162215
2,22.0,Asthenia,6,16162215
0,22.0,Surgery,,16162225
0,22.0,Death,,16162230
0,22.0,Death,,16162233
0,22.0,Headache,2,16162246
1,22.0,Epistaxis,6,16162246
2,22.0,Tumour marker increased,3,16162246
3,22.0,Renal failure,1,16162246
4,22.0,Abdominal pain upper,2,16162246
5,22.0,Night sweats,3,16162246
6,22.0,Blood pressure abnormal,2,16162246
7,22.0,Migraine,2,16162246
8,22.0,Vomiting,1,16162246
0,22.0,Skin fissures,3,16162280
1,22.0,Diarrhoea,3,16162280
2,22.0,Dermatitis,3,16162280
3,22.0,Peripheral sensory neuropathy,3,16162280
4,22.0,Nail bed inflammation,3,16162280
5,22.0,Dermatitis bullous,3,16162280
6,22.0,Constipation,3,16162280
7,22.0,Anaemia,1,16162280
8,22.0,Rhinitis,3,16162280
0,22.0,Metastases to abdominal wall,6,16162300
1,22.0,Ovarian cancer recurrent,6,16162300
2,22.0,Malignant neoplasm progression,6,16162300
3,22.0,Metastasis,6,16162300
4,22.0,Tumour marker increased,6,16162300
5,22.0,Drug intolerance,6,16162300
6,22.0,Carbohydrate antigen 125 increased,6,16162300
0,22.0,Depression,6,16162310
1,22.0,Asthenia,6,16162310
0,22.0,Fatigue,6,16162341
1,22.0,Nausea,6,16162341
2,22.0,Decreased appetite,6,16162341
3,22.0,Arthralgia,6,16162341
0,22.0,Pneumonia,,16162363
1,22.0,Therapy cessation,,16162363
0,22.0,Cerebrovascular accident,,16162376
1,22.0,Accidental death,,16162376
2,22.0,International normalised ratio decreased,,16162376
0,22.0,Neutrophil count decreased,1,16162408
1,22.0,Decreased appetite,1,16162408
2,22.0,Pyrexia,1,16162408
3,22.0,White blood cell count decreased,1,16162408
0,22.0,Muscle spasms,,16162409
0,22.0,Death,,16162450
0,22.0,Metastases to lung,,16162452
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16162452
0,22.0,Pneumonia,,16162453
0,22.0,Death,5,16162462
0,22.0,Acute kidney injury,6,16162463
0,22.0,Pulmonary oedema,6,16162465
0,22.0,Nausea,1,16162495
1,22.0,Internal haemorrhage,1,16162495
2,22.0,Vomiting,5,16162495
3,22.0,Septic shock,5,16162495
0,22.0,Thrombocytopenia,3,16162502
1,22.0,Anaemia,3,16162502
0,22.0,Musculoskeletal pain,,16162534
0,22.1,Haemoptysis,1,16162600
1,22.1,Febrile neutropenia,1,16162600
0,22.0,Product dose omission,6,16162606
1,22.0,Ill-defined disorder,6,16162606
0,22.0,Dysphonia,,16162617
1,22.0,Constipation,,16162617
2,22.0,Fatigue,,16162617
3,22.0,Off label use,,16162617
4,22.0,Asthenia,3,16162617
5,22.0,Hyperglycaemia,,16162617
6,22.0,Asthenia,,16162617
7,22.0,Dysphonia,,16162617
8,22.0,Renal failure,3,16162617
0,22.1,Product dose omission,1,16162710
1,22.1,Urinary tract infection,1,16162710
0,22.0,Malaise,1,16162729
1,22.0,Dyspnoea,1,16162729
2,22.0,Wheezing,1,16162729
3,22.0,Fatigue,1,16162729
0,22.0,Bone pain,1,16162759
1,22.0,Constipation,1,16162759
2,22.0,Fatigue,1,16162759
3,22.0,Obstruction gastric,1,16162759
4,22.0,Vomiting,1,16162759
5,22.0,Vomiting,1,16162759
6,22.0,Hyperhidrosis,1,16162759
0,22.0,Malignant neoplasm progression,3,16162765
0,22.0,Thrombotic cerebral infarction,6,16162794
0,22.1,Off label use,6,16162806
1,22.1,Hypophysitis,6,16162806
2,22.1,Adrenocorticotropic hormone deficiency,6,16162806
3,22.1,Autoimmune thyroiditis,3,16162806
4,22.1,Urinary tract infection,2,16162806
5,22.1,Sepsis,2,16162806
6,22.1,Adrenal insufficiency,2,16162806
0,22.0,Metastases to central nervous system,6,16162842
1,22.0,Radiation pneumonitis,2,16162842
0,22.0,Platelet count decreased,6,16162849
1,22.0,Fatigue,3,16162849
2,22.0,Muscle spasms,6,16162849
3,22.0,White blood cell count decreased,3,16162849
4,22.0,Haemoglobin decreased,6,16162849
5,22.0,Dizziness,6,16162849
6,22.0,Nausea,6,16162849
7,22.0,Asthenia,3,16162849
8,22.0,Arthralgia,6,16162849
9,22.0,Contusion,6,16162849
0,22.0,Pneumatosis intestinalis,6,16162870
0,22.0,Dizziness,6,16162899
1,22.0,Prostate cancer,3,16162899
2,22.0,Vomiting,6,16162899
3,22.0,Decreased appetite,6,16162899
0,22.1,Platelet count decreased,6,16162920
1,22.1,Performance status decreased,6,16162920
2,22.1,White blood cell count decreased,6,16162920
3,22.1,Bone marrow failure,6,16162920
4,22.1,Hepatic function abnormal,6,16162920
0,22.0,Tumour flare,1,16162947
1,22.0,Malignant neoplasm progression,6,16162947
2,22.0,Pleural effusion,6,16162947
0,22.0,Tumour flare,1,16162970
1,22.0,Malignant neoplasm progression,6,16162970
0,22.0,Diarrhoea,3,16162986
1,22.0,Rectal perforation,3,16162986
2,22.0,Portal venous gas,1,16162986
0,22.0,Lung disorder,5,16163028
0,22.1,Gangrene,2,16163029
1,22.1,Chest pain,6,16163029
2,22.1,Polycythaemia,2,16163029
3,22.1,Peripheral artery thrombosis,2,16163029
4,22.1,Back pain,6,16163029
0,22.0,Constipation,6,16163039
1,22.0,Depression,6,16163039
2,22.0,Memory impairment,6,16163039
3,22.0,Nausea,6,16163039
4,22.0,Herpes zoster,1,16163039
5,22.0,Blood count abnormal,6,16163039
6,22.0,Epistaxis,6,16163039
7,22.0,Asthenia,6,16163039
0,22.0,Renal impairment,1,16163098
0,22.0,Blood count abnormal,6,16163101
0,22.0,Gait disturbance,6,16163107
0,22.0,Death,5,16163127
0,22.0,Death,,16163138
0,22.0,Brain oedema,6,16163150
0,22.0,Death,5,16163192
0,22.0,Urinary retention,2,16163230
1,22.0,Neoplasm recurrence,2,16163230
2,22.0,Inappropriate schedule of product administration,6,16163230
0,22.0,Anaemia,6,16163231
1,22.0,Renal impairment,2,16163231
2,22.0,Malaise,6,16163231
0,22.0,Disease progression,6,16163256
0,22.0,Device related infection,1,16163259
1,22.0,Rash,1,16163259
2,22.0,Drug level increased,1,16163259
3,22.0,Acute kidney injury,1,16163259
4,22.0,Pneumonia,1,16163259
5,22.0,Drug interaction,6,16163259
0,22.0,Neuropathy peripheral,6,16163281
1,22.0,Weight increased,6,16163281
0,22.0,Death,5,16163284
0,22.0,Deformity,3,16163299
1,22.0,Anhedonia,6,16163299
2,22.0,Injury,6,16163299
3,22.0,Discomfort,6,16163299
4,22.0,Emotional distress,6,16163299
5,22.0,Pain,6,16163299
6,22.0,Alopecia,3,16163299
7,22.0,Anxiety,6,16163299
0,22.0,Hypoglycaemia,2,16163320
0,22.1,Malignant neoplasm progression,6,16163324
1,22.1,Hepatic function abnormal,1,16163324
2,22.1,Tracheal stenosis,6,16163324
3,22.1,Pneumonitis,2,16163324
0,22.0,Medication error,6,16163349
1,22.0,Disease progression,6,16163349
0,22.0,Mucosal inflammation,6,16163363
1,22.0,Breast cancer recurrent,1,16163363
2,22.0,Multiple-drug resistance,6,16163363
0,22.0,Death,5,16163455
0,22.0,Abdominal pain upper,3,16163473
0,22.0,Abdominal distension,2,16163554
1,22.0,Foot fracture,3,16163554
2,22.0,Dry mouth,3,16163554
3,22.0,Ligament sprain,3,16163554
4,22.0,Pancreatitis,2,16163554
5,22.0,Product use in unapproved indication,3,16163554
6,22.0,Glossodynia,3,16163554
7,22.0,Blood pressure increased,1,16163554
8,22.0,Glycosylated haemoglobin increased,3,16163554
9,22.0,Fall,1,16163554
10,22.0,Rib fracture,3,16163554
11,22.0,Dyspnoea,3,16163554
12,22.0,Oedema peripheral,2,16163554
13,22.0,Hypoglycaemia,1,16163554
14,22.0,Weight increased,3,16163554
15,22.0,Decreased appetite,2,16163554
16,22.0,Nausea,2,16163554
17,22.0,Gastric disorder,6,16163554
18,22.0,Fatigue,3,16163554
0,22.0,Cardiac failure,1,16163577
1,22.0,Ventricular hypokinesia,6,16163577
2,22.0,Mood altered,6,16163577
3,22.0,Asthenia,6,16163577
4,22.0,Cough,6,16163577
5,22.0,Lymphoma,6,16163577
6,22.0,Pulmonary mass,6,16163577
7,22.0,Malaise,6,16163577
8,22.0,Neoplasm,6,16163577
9,22.0,Fatigue,6,16163577
10,22.0,Ejection fraction decreased,6,16163577
11,22.0,Palpitations,6,16163577
12,22.0,Exercise tolerance decreased,6,16163577
13,22.0,Left ventricular enlargement,6,16163577
14,22.0,Neoplasm progression,6,16163577
0,22.0,Disease progression,6,16163593
0,22.0,Disease progression,6,16163594
0,22.0,Disease progression,6,16163596
0,22.0,Oxygen saturation decreased,1,16163660
1,22.0,Hot flush,1,16163660
2,22.0,Dyspnoea,1,16163660
3,22.0,Somnolence,1,16163660
4,22.0,Dysphagia,1,16163660
5,22.0,Nausea,1,16163660
0,22.0,Cardiomyopathy,6,16163666
1,22.0,Bradycardia,6,16163666
2,22.0,Neoplasm progression,6,16163666
0,22.0,Injection site pain,6,16163674
1,22.0,Stoma site induration,2,16163674
2,22.0,Administration site necrosis,2,16163674
3,22.0,Injection site erythema,6,16163674
4,22.0,Skin ulcer,2,16163674
0,22.0,Malignant neoplasm progression,6,16163688
1,22.0,Metastases to lymph nodes,6,16163688
0,22.0,Pyrexia,1,16163726
1,22.0,Diarrhoea,1,16163726
2,22.0,Diarrhoea,1,16163726
3,22.0,Skin disorder,1,16163726
4,22.0,Dyspnoea,1,16163726
5,22.0,Pyrexia,1,16163726
6,22.0,Proteinuria,1,16163726
7,22.0,Odynophagia,1,16163726
8,22.0,Nausea,1,16163726
9,22.0,Chills,1,16163726
10,22.0,Urinary tract infection,1,16163726
11,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16163726
12,22.0,Stomatitis,1,16163726
13,22.0,Fatigue,1,16163726
0,22.0,Bone pain,1,16163736
1,22.0,Obstruction gastric,1,16163736
2,22.0,Constipation,1,16163736
3,22.0,Fatigue,1,16163736
4,22.0,Vomiting,1,16163736
5,22.0,Vomiting,1,16163736
6,22.0,Hyperhidrosis,1,16163736
0,22.0,Pancreatic carcinoma,6,16163739
1,22.0,Second primary malignancy,6,16163739
0,22.0,Malignant neoplasm progression,6,16163749
1,22.0,Decreased appetite,6,16163749
2,22.0,Anaemia,6,16163749
3,22.0,Arthralgia,6,16163749
4,22.0,Asthenia,6,16163749
0,22.0,Renal disorder,3,16163802
0,22.0,Post procedural haemorrhage,6,16163816
1,22.0,Blood pressure increased,6,16163816
2,22.0,Death,5,16163816
3,22.0,Ammonia increased,6,16163816
4,22.0,Asthenia,6,16163816
0,22.0,Cerebral artery thrombosis,2,16163817
0,22.0,Neurotoxicity,3,16163832
0,22.0,Bone pain,4,16163841
0,22.0,Myocardial ischaemia,5,16163933
0,22.0,Hypersensitivity,6,16163954
1,22.0,Thrombocytopenia,6,16163954
2,22.0,Skin toxicity,6,16163954
3,22.0,Product use in unapproved indication,6,16163954
0,22.0,Death,5,16163961
0,22.0,Cataract,2,16163972
0,22.0,Anxiety,6,16163991
1,22.0,Emotional distress,6,16163991
2,22.0,Pain,6,16163991
3,22.0,Impaired quality of life,6,16163991
4,22.0,Alopecia,2,16163991
5,22.0,Psychological trauma,6,16163991
0,22.0,Cardiac failure congestive,2,16163998
0,22.0,Psychological trauma,6,16164029
1,22.0,Alopecia,3,16164029
0,22.0,Alopecia,2,16164031
0,22.0,Alopecia,2,16164036
0,22.0,Alopecia,2,16164058
1,22.0,Psychological trauma,6,16164058
0,22.0,Psychological trauma,6,16164064
1,22.0,Alopecia,3,16164064
0,22.0,Alopecia,2,16164066
1,22.0,Psychological trauma,6,16164066
0,22.0,Alopecia,2,16164079
1,22.0,Psychological trauma,6,16164079
0,22.0,Eczema,1,16164088
1,22.0,Pruritus,1,16164088
2,22.0,Oedema peripheral,1,16164088
0,22.0,Alopecia,2,16164093
0,22.0,Alopecia,3,16164099
0,22.0,Alopecia,3,16164113
0,22.0,Alopecia,2,16164137
0,22.0,Hypertransaminasaemia,2,16164246
0,22.0,Platelet count decreased,3,16164268
1,22.0,Rash,,16164268
2,22.0,Off label use,,16164268
3,22.0,Immune thrombocytopenic purpura,3,16164268
4,22.0,Renal failure,,16164268
0,22.0,Diarrhoea,1,16164317
1,22.0,Mucosal inflammation,1,16164317
2,22.0,Cellulitis,3,16164317
3,22.0,Rash,1,16164317
4,22.0,Pain in extremity,3,16164317
0,22.0,Hemiparesis,3,16164318
1,22.0,Cerebrovascular accident,1,16164318
0,22.0,Aortic valve stenosis,6,16164325
0,22.0,Pericardial effusion,6,16164326
0,22.0,Sepsis,6,16164327
0,22.0,Bone marrow failure,3,16164335
0,22.0,Product dose omission,6,16164364
1,22.0,Peripheral swelling,3,16164364
2,22.0,Asthenia,3,16164364
0,22.1,Injection site cellulitis,6,16164370
1,22.1,Pyrexia,1,16164370
2,22.1,Product preparation issue,6,16164370
3,22.1,Inflammation,6,16164370
4,22.1,Septic shock,3,16164370
5,22.1,Injection site erythema,6,16164370
0,22.0,Haematuria,1,16164380
1,22.0,Haemophagocytic lymphohistiocytosis,2,16164380
0,22.0,Fatigue,2,16164386
1,22.0,Pulmonary embolism,2,16164386
0,22.0,Malaise,1,16164400
1,22.0,Decreased appetite,1,16164400
2,22.0,Pyrexia,1,16164400
0,22.1,Abdominal pain,6,16164402
1,22.1,Intentional product use issue,6,16164402
2,22.1,Diarrhoea,6,16164402
3,22.1,Renal failure,6,16164402
4,22.1,Urinary tract infection,6,16164402
5,22.1,Failure to thrive,6,16164402
6,22.1,Rectal haemorrhage,6,16164402
7,22.1,Nausea,6,16164402
8,22.1,Dehydration,6,16164402
0,22.0,White blood cell count decreased,6,16164414
1,22.0,Nausea,6,16164414
2,22.0,Death,5,16164414
3,22.0,Drug ineffective,5,16164414
4,22.0,Pleural effusion,2,16164414
5,22.0,Vomiting,6,16164414
6,22.0,Anaphylactic shock,6,16164414
0,22.0,Peripheral sensory neuropathy,6,16164424
1,22.0,Pain,6,16164424
2,22.0,Urinary tract infection,6,16164424
3,22.0,Orthostatic intolerance,6,16164424
4,22.0,Sleep apnoea syndrome,6,16164424
5,22.0,Tongue disorder,2,16164424
6,22.0,Dysphagia,2,16164424
7,22.0,Folate deficiency,6,16164424
8,22.0,Weight decreased,6,16164424
9,22.0,Hypotonia,2,16164424
10,22.0,Motor neurone disease,6,16164424
11,22.0,Syncope,1,16164424
12,22.0,Malignant neoplasm progression,6,16164424
13,22.0,Dysarthria,2,16164424
0,22.0,Pancreatitis acute,6,16164468
1,22.0,Leukopenia,2,16164468
2,22.0,Neutropenia,2,16164468
3,22.0,Ascites,6,16164468
0,22.0,Product use in unapproved indication,6,16164476
1,22.0,Tumour pseudoprogression,6,16164476
0,22.0,Hepatotoxicity,1,16164499
0,22.0,Cerebrovascular accident,6,16164501
0,22.0,Ill-defined disorder,6,16164502
1,22.0,Neutropenia,1,16164502
0,22.0,Platelet count decreased,3,16164532
1,22.0,Malaise,3,16164532
2,22.0,Nausea,3,16164532
3,22.0,Pyrexia,6,16164532
4,22.0,Proteinuria,6,16164532
5,22.0,Coma,6,16164532
6,22.0,Hypertension,3,16164532
7,22.0,Catatonia,6,16164532
8,22.0,Constipation,3,16164532
9,22.0,Dizziness,6,16164532
10,22.0,Asthenia,3,16164532
11,22.0,Emotional disorder,6,16164532
12,22.0,Initial insomnia,6,16164532
13,22.0,Headache,6,16164532
14,22.0,Epistaxis,6,16164532
15,22.0,Vomiting,2,16164532
16,22.0,Hypoaesthesia,6,16164532
17,22.0,Sinusitis,6,16164532
18,22.0,Lethargy,6,16164532
19,22.0,Fatigue,6,16164532
20,22.0,White blood cell count decreased,6,16164532
21,22.0,Nephropathy,6,16164532
22,22.0,Dehydration,6,16164532
23,22.0,Productive cough,3,16164532
0,22.0,Product use in unapproved indication,6,16164547
1,22.0,Diarrhoea,6,16164547
2,22.0,Laboratory test abnormal,6,16164547
3,22.0,Intestinal obstruction,6,16164547
0,22.0,Metastases to bone,6,16164561
0,22.0,Breast cancer,6,16164578
1,22.0,Malignant neoplasm progression,6,16164578
0,22.0,Metastases to bone,6,16164598
0,22.0,Blood creatinine increased,2,16164631
1,22.0,Tubulointerstitial nephritis,6,16164631
0,22.0,Electrocardiogram abnormal,1,16164637
1,22.0,Acute myocardial infarction,1,16164637
0,22.0,Malignant neoplasm progression,5,16164698
0,22.0,Neutrophil count decreased,1,16164701
0,22.0,Malignant neoplasm progression,6,16164744
1,22.0,Immune-mediated hepatitis,1,16164744
0,22.0,Pulmonary infarction,6,16164761
1,22.0,Oxygen saturation decreased,6,16164761
2,22.0,Pleural effusion,6,16164761
3,22.0,Pericardial effusion,6,16164761
4,22.0,Flushing,6,16164761
5,22.0,Blood potassium increased,6,16164761
6,22.0,Blood creatinine increased,6,16164761
7,22.0,Diarrhoea,5,16164761
8,22.0,Cardiac failure,6,16164761
9,22.0,Back pain,6,16164761
10,22.0,Pulmonary oedema,6,16164761
11,22.0,Erythema,6,16164761
12,22.0,Pain in extremity,6,16164761
13,22.0,Cardiac hypertrophy,6,16164761
14,22.0,Pulmonary embolism,5,16164761
15,22.0,Myocardial fibrosis,6,16164761
0,22.0,Renal impairment,1,16164773
1,22.0,Hepatic function abnormal,1,16164773
0,22.0,Bone marrow failure,6,16164774
1,22.0,Abdominal discomfort,6,16164774
2,22.0,Abdominal distension,6,16164774
3,22.0,Leukopenia,6,16164774
4,22.0,Nausea,6,16164774
5,22.0,Fatigue,6,16164774
6,22.0,Arthralgia,6,16164774
0,22.0,Neuropathy peripheral,3,16164783
1,22.0,Vomiting,6,16164783
2,22.0,Arthralgia,6,16164783
3,22.0,Diarrhoea,6,16164783
4,22.0,Condition aggravated,3,16164783
5,22.0,Abdominal symptom,2,16164783
6,22.0,Hypotension,6,16164783
7,22.0,Stomatitis,6,16164783
8,22.0,Hypoaesthesia,3,16164783
9,22.0,Product dose omission,6,16164783
10,22.0,Epistaxis,6,16164783
11,22.0,Pyrexia,6,16164783
12,22.0,Laboratory test abnormal,6,16164783
13,22.0,Dizziness,6,16164783
14,22.0,Influenza,6,16164783
15,22.0,Fatigue,6,16164783
16,22.0,Food intolerance,6,16164783
0,22.0,Pleurisy,6,16164795
1,22.0,Hepatic failure,5,16164795
2,22.0,Renal failure,5,16164795
3,22.0,General physical health deterioration,5,16164795
0,22.0,Bone marrow failure,2,16164818
0,22.0,Thrombocytopenia,1,16164846
